Last reviewed · How we verify
NESP - Novel Erythropoiesis Stimulating Protein
NESP - Novel Erythropoiesis Stimulating Protein is a Small molecule drug developed by Mirhashemi, Ramin, M.D.. It is currently in Phase 2 development.
At a glance
| Generic name | NESP - Novel Erythropoiesis Stimulating Protein |
|---|---|
| Sponsor | Mirhashemi, Ramin, M.D. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Luspatercept + Darbepoetin in MDS (PHASE2)
- Vafseo Outcomes In-Center Experience (PHASE3)
- Choices About Genetic Testing And Learning Your Risk With Smart Technology (NA)
- Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants (PHASE2)
- Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan (PHASE3)
- Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan (PHASE3)
- A Study to Evaluate Efficacy and Safety of QLG1218(Daprodustat) in Chinese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD) (PHASE3)
- Darbepoetin in Patients Candidates for Liver Transplant. (EPO-LT Trial) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NESP - Novel Erythropoiesis Stimulating Protein CI brief — competitive landscape report
- NESP - Novel Erythropoiesis Stimulating Protein updates RSS · CI watch RSS
- Mirhashemi, Ramin, M.D. portfolio CI
Frequently asked questions about NESP - Novel Erythropoiesis Stimulating Protein
What is NESP - Novel Erythropoiesis Stimulating Protein?
NESP - Novel Erythropoiesis Stimulating Protein is a Small molecule drug developed by Mirhashemi, Ramin, M.D..
Who makes NESP - Novel Erythropoiesis Stimulating Protein?
NESP - Novel Erythropoiesis Stimulating Protein is developed by Mirhashemi, Ramin, M.D. (see full Mirhashemi, Ramin, M.D. pipeline at /company/mirhashemi-ramin-m-d).
What development phase is NESP - Novel Erythropoiesis Stimulating Protein in?
NESP - Novel Erythropoiesis Stimulating Protein is in Phase 2.